A Strategic Alliance: Joining AMRC as a Founding Member
Joining AMRC as a founding member in 2024 was an easy decision for Chief Development Officer Jeff Kingsley and the team at Centricity Research. They understood that working with AMRC members would give sites “a big voice with sponsors and regulators,” he says.
A maturing industry, bolstered by an organization like AMRC, gives sites the ability to “team up and have a larger voice,” Kingsley says, much like CROs and Sponsors have done in the past. “AMRC helps give competing companies a way to work together to move the entire industry forward,” he adds.
Jeff Kingsley’s Professional Journey
Kinglsey brings decades of varied experience to his clinical trial work. Fueled by an “innate love of learning and teaching,” Kingsley found himself attracted to clinical research early in his medical career and a resident. “I was immediately engaged by the research I saw internists doing in our medical practice.”
As his career progressed with a focus on clinical trials, Kingsley became a PI, then founded his own site after leaving his practice as a “cradle to grave” general medical practitioner.
A firm believer in clinical trial then and now, Kingsley is enthusiastic about what’s been achieved in the past and what’s to come in the future. “I’ve seen how clinical research can advance healthcare by doing more than just treatment.”
Kingsley is a widely respected clinical trial subject matter expert. He regularly speaks at conferences and is a frequently published author covering a wide array of topics, with an emphasis on how to think outside the box to advance the entire clinical trial industry to the benefit of patients and practitioners.
He’s also kept busy with Centricity. The network has more than 35 sites, access to nearly 8 million patients, and more than 150 active investigators across Canada and the United States, making Centricity one of the largest clinical research networks in North America.
The Power of Diversification: Why Centricity Avoids a Single Specialty
Centricity Research is a fully centralized multisite clinical research corporation (MCRC), specializing in conducting Phase I-IV clinical trials in over 35 therapeutic areas: inpatient and outpatient; pharmaceutical, biotechnology, and medical device trials. In fact, its breadth of trial experience and expertise is by design, Kinglsey says.
“At Centricity, our specialty is not having a specialty; we are very diversified, and try not to focus on just one area,” Kingsley explains.
